MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impaired Color Vision in Patients with DLB or Prodromal DLB.

B. Tousi, P. Flanigan, M. Khosravi (Cleveland, OH, USA)

Meeting: 2017 International Congress

Abstract Number: 836

Keywords: Dementia with Lewy bodies (DLB), Lewy bodies, Rapid eye movement(REM)

Session Information

Date: Wednesday, June 7, 2017

Session Title: Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated with other features of the disease.

Background: Color vision abnormalities have been well-described in PD but rarely in DLB, especially at the office setting.

Methods: We performed a retrospective chart review of patients with DLB, and patients with MCI who were suspected to be in the early phase of DLB (pro-DLB). All patients had an online 15-hue color vision arrangement test as a part of the clinical assessment. The test took less than 2 minutes and the interpretation of results was available by the end of the test as negative or positive for the type of color vision impairment.

Results: The 27 patients included had a median age of 76.7 years and 37% (n= 10) were female. 20 patients with DLB (MoCA=15.8) and 7 with pro DLB ( MoCA=21.6). Only one patient with DLB had a known history of color vision impairment from a young age. New-onset color vision impairment was found in 29% of pro-DLB patients (n=2), and 79% of DLB patients (n=15). The color vision impairment type was as follows: pro-DLB (2 deuteranopia), DLB (10 protanopia, 3 deuteranopia, and 2 tritanopia).

The clinical signs and symptoms of patients with DLB were analyzed to evaluate factors associated with color vision impairment. Of these 20 patients, 75% (n=15) had REM behavior disorder, 80% (n=16) had anosmia, 55% (n=11) had tremor, 55% (n=11) had bradykinesia, 55% (n=11) had rigidity, 65% (n=13) had postural instability, 90% (n=18) had visual hallucinations, and 50% (n=10) had autonomic dysfunction.

Several differences existed between patients with color vision impairment vs. those without in this cohort of 27 patients. Patients with color vision impairment were more likely to have 1 or more Parkinsonian feature (95% vs. 63%, p=0.04), tended towards having lower MOCA scores (mean = 16 vs. 20, p=0.07), and were more likely to have lower visuospatial MOCA scores (2.0 vs. 3.3, p=0.02).

Conclusions: Color vision impairment was found in most patients with DLB and was highly specific for DLB versus Alzheimer’s. Cluster analysis showed that color vision impairment tended to be more prevalent in patients with more features of DLB although was found in less symptomatic DLB and pro-DLB patients as well. Further investigation is needed to determine if incorporation of the 15-hue color test may improve the accuracy of diagnosis of DLB.

To cite this abstract in AMA style:

B. Tousi, P. Flanigan, M. Khosravi. Impaired Color Vision in Patients with DLB or Prodromal DLB. [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/impaired-color-vision-in-patients-with-dlb-or-prodromal-dlb/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impaired-color-vision-in-patients-with-dlb-or-prodromal-dlb/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley